Fraunhofer Institute for Toxicology and Experimental Medicine
Hannover, Germany
Research institute in Hanover, Lower Saxony
Nikolai-Fuchs-Straße 1, 30625 Hannover
About Fraunhofer Institute for Toxicology and Experimental Medicine
"Pioneers for sustainable health: Das Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM ist eines von über 70 Instituten der Fraunhofer-Gesellschaft, der größten Organisation für anwendungsorientierte Forschung in Europa. Ziele der Auftragsforschung am Fraunhofer ITEM sind es, den Menschen in unserer industrialisierten Welt vor gesundheitlicher Gefährdung zu schützen und an der Entwicklung neuer therapeutischer Ansätze mitzuwirken. Mit Schwerpunkt auf der Atemwegsforschung umfasst das FuE-Portfolio drei Geschäftsfelder: die Arzneimittelentwicklung, die Chemikalienbewertung sowie die translationale Medizintechnik."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fraunhofer-Institute of Toxicology and Experimental Medicine
9
Sterna Biologicals GmbH & Co. KG
2
Clinical Trials at Fraunhofer Institute for Toxicology and Experimental Medicine
During the past decade, Fraunhofer Institute for Toxicology and Experimental Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season
2007-06-01
2008-02-01
Completed
70
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
2011-01-01
2011-05-01
Completed
18
Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma
2012-04-01
2012-08-01
Completed
24
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
2012-12-01
2013-12-01
Completed
38
Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers
2015-08-01
2017-03-01
Completed
116
Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)
2018-04-10
2018-12-31
Completed
21
Second Follow-up Study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers
2021-05-25
2023-03-31
Enrolling by invitation
118
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fraunhofer Institute for Toxicology and Experimental Medicine"
#1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Federal Institute for Occupational Safety and Health (BAuA)/Germany)" with 1 trials as a collaborator and "Hannover Medical School" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Fraunhofer Institute for Toxicology and Experimental Medicine
According to Clinical.Site data, the most researched conditions in "Fraunhofer Institute for Toxicology and Experimental Medicine" are
"Healthy" (3 trials), "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Allergic Rhinitis" (1 trials) and "Allergy to House Dust Mite" (1 trials). Many other conditions were trialed in "Fraunhofer Institute for Toxicology and Experimental Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Fraunhofer Institute for Toxicology and Experimental Medicine
Most popular intervention types in "Fraunhofer Institute for Toxicology and Experimental Medicine" are "Drug" (7 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "SB010" (2 trials), "Allergen-free air" (1 trials), "Bronchoscopy" (1 trials) and "Clean air" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fraunhofer Institute for Toxicology and Experimental Medicine
The vast majority of trials in "Fraunhofer Institute for Toxicology and Experimental Medicine" are
8 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Fraunhofer Institute for Toxicology and Experimental Medicine
Currently, there are NaN active trials in "Fraunhofer Institute for Toxicology and Experimental Medicine".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 10 completed trials in Fraunhofer Institute for Toxicology and Experimental Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fraunhofer Institute for Toxicology and Experimental Medicine, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 7 trials that are defined as “Not Applicable".